ID   IST-SL2
AC   CVCL_1314
DR   CLO; CLO_0006975
DR   CLDB; cl2909
DR   ArrayExpress; E-MTAB-3610
DR   CCLE; ISTSL2_LUNG
DR   Cell_Model_Passport; SIDM00230
DR   ChEMBL-Cells; CHEMBL3308871
DR   ChEMBL-Targets; CHEMBL2366101
DR   Cosmic; 753565
DR   Cosmic; 1995458
DR   Cosmic-CLP; 753565
DR   DepMap; ACH-002145
DR   GDSC; 753565
DR   GEO; GSM1669945
DR   ICLC; HTL97010
DR   LINCS_LDP; LCL-1869
DR   Wikidata; Q54898351
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Genome ancestry: African=0.3%; Native American=0.72%; East Asian, North=0%; East Asian, South=0.93%; South Asian=4.5%; European, North=46.2%; European, South=47.35% (PubMed=30894373).
CC   Derived from metastatic site: Pleural effusion.
ST   Source(s): Cosmic-CLP; ICLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 18
DI   NCIt; C4917; Small cell lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-07-19; Version: 21
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M.,
RA   Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M.,
RA   Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A.,
RA   Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//